Essential fatty acid deficiency occurs when the body does not get enough linoleic acid (an omega-6 fat) or alpha-linolenic acid (an omega-3 fat), the two fats humans cannot manufacture internally. The condition shows up most visibly as dry, scaly skin, but it can quietly affect the brain, eyes, liver, immune system, and growth. Full-blown deficiency was once considered rare outside hospital nutrition settings, yet milder shortfalls tied to genetics, gut disease, or restrictive diets are increasingly recognized.
Why These Two Fats Are Called Essential
In 1929, George and Mildred Burr demonstrated that rats fed a completely fat-free diet developed a recognizable disease that could be prevented by adding back specific fatty acids. They identified linoleic acid as the critical nutrient and later showed that alpha-linolenic acid, its omega-3 counterpart, was also essential.1PubMed Central. Discovery of essential fatty acids “Essential” in nutrition means the body needs the substance but cannot synthesize it from scratch. Both linoleic acid and alpha-linolenic acid must come from food or, in clinical settings, from intravenous lipid formulas. Once absorbed, the body uses a shared set of enzymes to convert these parent fats into longer-chain derivatives like arachidonic acid (from linoleic acid) and DHA and EPA (from alpha-linolenic acid). When the parent fats run low, those downstream products drop as well, and a cascade of problems follows.
Skin Symptoms Are Usually the First Sign
The skin is often where essential fatty acid deficiency (EFAD) announces itself. Linoleic acid plays a direct structural role in the outermost layer of skin, where it is built into specialized fat molecules that form the water barrier. Without enough linoleic acid, the skin cannot hold moisture in. Animal studies show that transepidermal water loss, the rate at which water escapes through the skin, can climb to five times normal levels during EFAD.2Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism. Effects of essential fatty acid deficiency on epidermal O-acylsphingolipids and transepidermal water loss in young pigs The progressive water loss tracks with linoleic acid being replaced by oleic acid in the skin’s barrier lipids.
What does this look like in a person? Dry, flaky, sometimes eczema-like patches, particularly on the scalp, face, and skin folds. One well-documented case involved a 19-year-old man maintained on fat-free intravenous feeding who developed scalp dermatitis, hair loss, and depigmentation of his hair.3PubMed. Human essential fatty acid deficiency: treatment by topical application of linoleic acid These changes reversed once linoleic acid was reintroduced.
The mechanism is not about general dryness the way winter air dries skin. Linoleic acid is physically incorporated into specific ceramide molecules in the epidermis. When the body substitutes oleic acid for the missing linoleic acid, those ceramides still form, but they create a leakier barrier.4Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier Applying linoleic acid directly to the skin can restore the barrier locally even before the rest of the body catches up, which tells researchers that this is a structural defect at the skin surface, not just a downstream consequence of inflammation.5Journal of Investigative Dermatology. The Permeability Barrier in Essential Fatty Acid Deficiency: Evidence for a Direct Role for Linoleic Acid in Barrier Function
Neurological and Visual Effects
While the skin problems are the most visible, the nervous system and eyes may be the most consequential targets. DHA, the long-chain omega-3 fat derived from alpha-linolenic acid, is concentrated in retinal photoreceptors and brain gray matter. When omega-3 intake is inadequate, retinal rod cells become measurably less sensitive to light, and visual acuity development slows in infants.6PubMed. Essential fatty acids in visual and brain development DHA is considered conditionally essential for brain development in humans, meaning the body’s ability to make it from alpha-linolenic acid is too limited to keep up with the developing brain’s demand.
The consequences extend beyond infancy. Alpha-linolenic acid deficiency affects the functional development of both the retina and the visual cortex, and these effects have been documented in both preterm and full-term infant diets lacking adequate omega-3 fats.7PubMed. Role of essential fatty acids in the function of the developing nervous system Dietary DHA appears to support the maturation of the visual cortex, and both visual acuity and cognitive development seem to benefit from adequate supply.8PubMed. Nutrition in brain development and aging: role of essential fatty acids Adults with longstanding EFAD are less studied, but the logic is consistent: the brain and retina need a steady supply of these fats for membrane maintenance throughout life.
Liver Involvement and Systemic Signs
EFAD does not stop at the skin and nervous system. The liver is particularly vulnerable. In rat models of fat-free parenteral nutrition, fatty liver developed alongside biochemical EFAD within just four days, with liver linoleic acid plummeting from about 20% to 1% of total fatty acids.9PubMed. Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat-free parenteral nutrition The steatosis (fatty liver) likely results from a combination of ramped-up fat production in the liver and impaired ability to ship fat out into the bloodstream, both consequences of the missing essential fats.
Other systemic signs that have been reported in clinical EFAD include poor wound healing, increased susceptibility to infection, growth failure in children, and reduced intraocular pressure. In one study, patients on fat-free intravenous nutrition experienced a significant drop in eye pressure during the first week, from about 14 mmHg to about 9 mmHg.10PubMed Central. Essential fatty acid deficiency in total parenteral nutrition. Detection by changes in intraocular pressure That finding is more of a diagnostic curiosity than a symptomatic complaint, but it underscores how pervasively these fats affect tissue function.
The Most Common Cause Is Intravenous Feeding Without Fat
Historically, the clearest cases of EFAD have appeared in hospitalized patients receiving total parenteral nutrition (TPN) that either omits fat entirely or provides too little. When patients cannot eat and receive only glucose and amino acids through their veins, essential fatty acid levels drop fast. In critically ill surgical patients, linoleic acid fell below normal in two-thirds of patients within a single week of no oral intake, and Mead acid, the hallmark metabolite of EFAD, appeared in a quarter of patients that same week and in all patients by the third week.11The American Journal of Surgery. Essential fatty acid deficiency in critically III surgical patients
Modern parenteral nutrition formulas include lipid emulsions to prevent this, but the speed with which biochemical deficiency sets in highlights how slim the body’s reserves of these fats really are. There is very little storage buffer, especially in patients who were already malnourished before hospitalization.
Gut Disease, Surgery, and Restricted Diets
Outside the hospital, EFAD is most likely to develop in people who cannot absorb fat properly. Cystic fibrosis is a well-known example. The pancreatic insufficiency that accompanies most cases of CF impairs fat digestion, and EFAD in CF patients is closely associated with the risk of pulmonary infection, the most significant complication of the disease.12PubMed Central. Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex Other conditions that compromise fat absorption, including short bowel syndrome, Crohn’s disease, and chronic pancreatitis, carry similar risks.
Bariatric surgery, particularly procedures like Roux-en-Y gastric bypass that both restrict intake and reduce fat absorption, can alter essential fatty acid profiles. Research comparing gastric bypass with adjustable gastric banding found that both procedures affect plasma fatty acid composition, but gastric bypass adds a malabsorptive component on top of the dietary restriction.13PubMed. Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries Patients who have had weight-loss surgery and follow very low-fat diets afterward may be at particular risk.
Extreme dietary restriction can also produce EFAD in otherwise healthy people. Very low-fat diets, prolonged fasting regimens, or disordered eating patterns that eliminate most fat sources reduce linoleic and alpha-linolenic acid intake below what the body needs. These cases are less dramatic than hospital TPN scenarios, but they can still produce skin changes, poor healing, and shifts in fatty acid profiles that signal early deficiency.
Genetics Can Predispose You to Functional Deficiency
Even with adequate dietary fat, some people are genetically less efficient at converting parent essential fatty acids into their long-chain derivatives. Variations in the FADS1 and FADS2 genes, which encode the desaturase enzymes responsible for this conversion, are surprisingly common and have outsized effects. An early candidate gene study found that FADS gene cluster polymorphisms explained roughly 29% of the variance in arachidonic acid levels, a remarkably large genetic effect for a single nutrient pathway.14PubMed. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism People who carry the minor alleles of these variants tend to have higher levels of the unconverted parent fats and lower levels of the downstream products like arachidonic acid, EPA, and DHA.
This is not just a laboratory curiosity. In a study of Mexican Americans, individuals with two copies of the ancestral FADS haplotype produced markedly lower levels of both omega-6 and omega-3 long-chain fats, with circulating EPA falling below 5 nanograms per milliliter and the ratio of arachidonic acid to EPA reaching 30 to 1.15Frontiers in Nutrition. The influence of FADS genetic variation and omega-3 fatty acid deficiency on cardiometabolic disease risk in a Mexican American population Studies in Brazilian adults have confirmed that carriers of the minor alleles for key FADS variants show reduced conversion along both the omega-6 and omega-3 pathways.16PubMed Central. FADS1 and FADS2 Gene Polymorphisms Affect Omega-3 and Omega-6 Erythrocyte Fatty Acid Composition and Influence the Association Between Dietary Fatty Acid Intake and Lipid Profile in Brazilian Adults For these individuals, a diet that provides enough parent essential fatty acids for most people may still leave them functionally short of the downstream products their brains, eyes, and immune systems need.
How EFAD Is Diagnosed
When the body runs low on linoleic acid, the same enzymes that normally process it switch to processing oleic acid instead, producing an unusual omega-9 fat called Mead acid. Mead acid is normally present only in trace amounts, so its accumulation is a sensitive signal that something has gone wrong.17PubMed Central. The physiological and pathological properties of Mead acid, an endogenous multifunctional n-9 polyunsaturated fatty acid
The standard diagnostic tool is the Holman Index, which compares the level of Mead acid to the level of arachidonic acid in the blood. A ratio at or above 0.20 has historically been the threshold for diagnosing EFAD.18PubMed Central. In defense of the Holman index: Defining fatty acid deficiency The beauty of this test is that it reflects the body’s own metabolic response to deprivation rather than depending on a fixed reference range that might vary by age, sex, or diet. When essential fats are scarce, Mead acid goes up and arachidonic acid goes down, and the ratio captures both movements in a single number.
In practice, the Holman Index is mainly used in clinical nutrition settings, particularly for patients on long-term parenteral nutrition. It is not a routine screening test. Doctors more commonly suspect EFAD from the clinical picture: unexplained dermatitis, poor wound healing, and a nutritional history that raises red flags. The blood test confirms the suspicion and helps guide how aggressively to treat.
Premature Infants Are at Greatest Risk
Premature babies are uniquely vulnerable to EFAD for several reasons. They are born with smaller fat stores, their skin is thinner and loses water faster, and their demand for DHA during rapid brain growth is intense. In a study of preterm infants receiving fat-free parenteral nutrition, more than half of the most premature group developed biochemical EFAD, with some showing it by just five days of age.19PubMed. Essential fatty acid status of the premature infant during short-term fat-free parenteral nutrition The more premature the baby, the faster deficiency develops and the more severe it becomes. This has made early introduction of lipid-containing nutrition a standard part of neonatal intensive care.
Treatment With Intravenous Lipid Emulsions
For patients who cannot eat, the primary treatment for EFAD is intravenous lipid emulsion. The original formulations were based on soybean oil, which is rich in linoleic acid and effectively prevents or reverses biochemical deficiency. Newer mixed emulsions incorporate fish oil, olive oil, and medium-chain triglycerides alongside soybean oil. In neonatal piglet models, a mixed lipid emulsion improved bile flow and lowered bilirubin and inflammatory markers compared to pure soybean oil.20PubMed. Liver Disease, Systemic Inflammation, and Growth Using a Mixed Parenteral Lipid Emulsion, Containing Soybean Oil, Fish Oil, and Medium Chain Triglycerides, Compared With Soybean Oil in Parenteral Nutrition-Fed Neonatal Piglets
In adult ICU patients, switching from soybean-oil-only to a mixed lipid emulsion was associated with lower bilirubin levels and reduced urinary tract infection rates.21PubMed Central. Change to mixed lipid emulsion from soybean oil-based lipid emulsion for parenteral nutrition in hospitalized and critically ill adults improves outcomes: a pre–post-comparative study Studies of adults on long-term home parenteral nutrition have found that both mixed (soy/fish/olive/MCT) and olive-oil-based emulsions reduce the Mead acid marker of EFAD, though neither type pushed any patient above the 0.20 diagnostic threshold, meaning both adequately prevented deficiency.22PubMed. Effect of changing the lipid component of home parenteral nutrition in adults The shift toward mixed emulsions in clinical practice is driven less by EFAD prevention, which soybean oil handles well on its own, and more by concerns about liver health and inflammation during long-term use.
Topical Treatment Through the Skin
One of the more surprising findings in EFAD research is that essential fatty acids can be absorbed through the skin in amounts large enough to reverse the condition. In the case of the 19-year-old man on fat-free TPN mentioned earlier, daily topical application of safflower oil, which is about 60% to 70% linoleic acid, reversed the deficiency over 21 days. His blood ratio of Mead acid to arachidonic acid returned to normal, and the scalp dermatitis, hair loss, and hair color changes resolved.23JAMA Dermatology. Human Essential Fatty Acid Deficiency: Treatment by Topical Application of Linoleic Acid Sunflower seed oil applied to the skin has shown similar ability to correct the cutaneous signs of EFAD.24PubMed. Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower-seed oil to the skin
Topical treatment is not a substitute for proper lipid nutrition when oral or intravenous routes are available. But in emergency situations, or when venous access is limited and enteral feeding is not yet possible, rubbing a linoleic-acid-rich oil on the skin can serve as a bridge therapy. It is particularly relevant in neonatal care, where premature infants have large skin-surface-to-body-weight ratios and limited venous access.
Why Getting Omega-3s From Plant Sources Alone Can Be Difficult
Alpha-linolenic acid, the plant-based omega-3 found in flaxseed, walnuts, and canola oil, is technically the essential omega-3 fat. But the body’s conversion of alpha-linolenic acid to the longer-chain EPA and DHA that the brain and retina rely on is strikingly poor. Most human studies show that while some conversion to EPA occurs, the conversion to DHA is severely restricted.25PubMed. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Against a background diet high in saturated fat, roughly 6% of alpha-linolenic acid is converted to EPA and about 4% to DHA. When the diet is high in omega-6 fats instead, conversion drops by 40% to 50%.
This inefficiency matters because it means eating plenty of flaxseed oil does not guarantee adequate DHA levels. The absolute amount of alpha-linolenic acid consumed influences conversion more than the ratio of omega-6 to omega-3 in the diet.26The American Journal of Clinical Nutrition. Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio It is not enough to assume that alpha-linolenic acid will fill the body’s DHA needs through conversion alone.27PubMed Central. Are all n-3 polyunsaturated fatty acids created equal? For people who avoid fish and other direct sources of EPA and DHA, whether by dietary choice or allergy, this conversion bottleneck can quietly erode omega-3 status over time, especially if they also carry less efficient FADS gene variants.
Zinc Deficiency Can Mimic or Worsen EFAD
One clinical pitfall worth knowing about is the overlap between EFAD and zinc deficiency. The two conditions produce strikingly similar skin findings in both animals and humans, including dermatitis concentrated around body openings and on the extremities. This is not a coincidence. Zinc appears to be required for at least two steps in essential fatty acid metabolism: the initial conversion of linoleic acid to its first downstream product and the mobilization of later intermediates for prostaglandin production. At the same time, essential fatty acids may assist zinc absorption. A patient presenting with eczema-like skin changes and hair loss could have EFAD, zinc deficiency, or both, and treating only one without considering the other may leave symptoms incompletely resolved. Conditions like acrodermatitis enteropathica, total parenteral nutrition without adequate trace minerals, and anorexia nervosa can produce combined deficiencies of both nutrients.